The interplay between DNA topoisomerase 2α post-translational modifications and drug resistance - Archive ouverte HAL Access content directly
Journal Articles Cancer Drug Resistance Year : 2020

The interplay between DNA topoisomerase 2α post-translational modifications and drug resistance

Abstract

The type 2 DNA topoisomerases (Top2) are conserved enzymes and biomarkers for cell proliferation. The catalytic activities of the human isoform Top2α are essential for the regulation of DNA topology during DNA replication, transcription, and chromosome segregation. Top2α is a prominent target for anti-cancer drugs and is highly regulated by post-translational modifications (PTM). Despite an increasing number of proteomic studies, the extent of PTM in cancer cells and its importance in drug response remains largely uncharacterized. In this review, we highlight the different modifications affecting the human Top2α in healthy and cancer cells, taking advantage of the structure-function information accumulated in the past decades. We also overview the regulation of Top2α by PTM, the level of PTM in cancer cells, and the resistance to therapeutic compounds targeting the Top2 enzyme. Altogether, this review underlines the importance of future studies addressing more systematically the interplay between PTM and Top2 drug resistance.
Fichier principal
Vignette du fichier
islandora_96850.pdf (1.57 Mo) Télécharger le fichier
Origin Publisher files allowed on an open archive
Loading...

Dates and versions

hal-03013428 , version 1 (18-11-2020)

Identifiers

Cite

Christophe Lotz, Valerie Lamour. The interplay between DNA topoisomerase 2α post-translational modifications and drug resistance. Cancer Drug Resistance, 2020, 3, pp.149-160. ⟨10.20517/cdr.2019.114⟩. ⟨hal-03013428⟩
74 View
50 Download

Altmetric

Share

Gmail Mastodon Facebook X LinkedIn More